Theravance Biopharma, Inc. 4

Insufficient information was provided to determine who traded what in this Form 4.

The provided document does not contain any actual Form 4 content such as the reporting person’s name, issuer name, transaction dates, number of shares, prices, or post-transaction holdings, so the insider transaction details cannot be determined. Without the underlying Form 4 data or stock snapshot values, it is not possible to identify who traded, what security was involved, or the size and nature of the transaction.

Filing Facts

CIK

1583107

Ticker

TBPH

Form

4

Source Type

fda

Accession

0001877589-26-000002

Alert Tier

4